acetylleucyl-leucyl-norleucinal has been researched along with Atherogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, E; Liu, J; Tang, F; Wang, Q; Wei, Y; Zhang, S | 1 |
| Badimon, L; Berrozpe, M; Llorente-Cortés, V; Otero-Viñas, M; Royo, T | 1 |
2 other study(ies) available for acetylleucyl-leucyl-norleucinal and Atherogenesis
| Article | Year |
|---|---|
Calpain inhibitor prevents atherosclerosis in apolipoprotein E knockout mice by regulating mRNA expression of genes related to cholesterol uptake and efflux.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Aorta; Aortic Diseases; Atherosclerosis; ATP Binding Cassette Transporter 1; Calpain; Cholesterol; Cysteine Proteinase Inhibitors; Disease Models, Animal; Gene Expression Regulation; Leupeptins; Lipid Metabolism; Liver X Receptors; Macrophages, Peritoneal; Male; Mice, Inbred C57BL; Mice, Knockout, ApoE; Plaque, Atherosclerotic; PPAR gamma; RNA, Messenger; Scavenger Receptors, Class A | 2022 |
Sterol regulatory element binding proteins downregulate LDL receptor-related protein (LRP1) expression and LRP1-mediated aggregated LDL uptake by human macrophages.
Topics: Analysis of Variance; Atherosclerosis; Blotting, Western; Cells, Cultured; Cholesterol Esters; Coronary Vessels; Down-Regulation; Gene Expression Regulation; Humans; Leupeptins; Lipoproteins, LDL; Low Density Lipoprotein Receptor-Related Protein-1; Macrophages; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; RNA, Small Interfering; Statistics, Nonparametric; Sterol Regulatory Element Binding Proteins | 2007 |